Jean-pierre bizzari
Director
Pharmaceutical technology
Charak Pharma Pvt Ltd
New Zealand
Biography
Dr. Jean-Pierre Bizzari, M.D. has been Director of NORDIC NANOVECTOR ASA since May 19, 2016. Jean-Pierre Bizzari has significant industry experience from leadership positions in oncology with highly reputable companies as Celgene, Rhone-Poulenc and Sanofi-Aventis, where he was involved in the clinical development of several anticancer products, including Taxotere, Eloxatin, Revlimid, Vidaza, Abraxane and Irinotecan. He is a world-renowned oncology expert, member of the Scientific Advisory Board of the French National Cancer Institute and European Organization of Research and Treatment of Cancer and Chairman of the New Drug Advisory Committee. He is also an active board member in various biotech companies in France and the USA. Dr. Bizzari holds a medical degree with specialization in oncology from the University of Nice (France) completed with training at the Pitie-Salpetriere hospital in Paris, the Ontario Cancer Institute and at the Montreal Mac Gill Cancer Center in Canada.
Research Interest
Nanomedicine Design of Nanodrugs Personalized Nanomedicine Nanomaterials for drug delivery
